WHAT'S HOT IN LIFE
#LABLIFE
ABCLONAL
Recent Posts

FDA OKs Abbott's COVID-19 Rapid Test Kit

Posted by Dennis Miao on Sep 17, 2020 12:00:00 PM

In a press release on August 26th, 2020, Abbott Laboratories announced that they were issued an emergency use authorization (EUA) by the FDA for their new, rapid point-of-care COVID-19 antigen test. Branded as the “BinaxNOW COVID-19 Ag Card”, the test is unique compared to the more prevalent molecular-based detection tests for COVID-19 in that it utilizes a lateral flow assay, similar to traditional over-the-counter pregnancy tests. Contained in a portable, credit-card sized device, Abbott claims that the test can deliver results in as little as 15 minutes, representing a significant reduction in time compared to RT-PCR-based tests that have turnaround times on a scale of hours rather than minutes.

 

Pricing in a Pandemic: Gilead Announces Remdesivir Pricing

Posted by Dennis Miao on Jul 22, 2020 1:35:25 PM

During these past few months, the push to discover effective treatments and vaccines against COVID-19 has largely overshadowed another vitally important aspect of drug development: drug pricing. Let’s take a look at a recent example from pharma giant Gilead, who recently announced the pricing for its promising COVID-19 treatment remdesivir.

 

Featured Product Weekly: SARS-CoV-2 Neutralizing Antibody

Posted by Dennis Miao on Jul 8, 2020 5:28:42 PM

In direct support of the fight against the novel coronavirus and the world's effort to understand more about the mechanisms of the COVID-19 disease, we're proud to announce the arrival of our SARS-CoV-2 Neutralizing Antibody.

 

Featured Product Weekly: SARS-CoV-2 Sandwich ELISA Kits

Posted by Dennis Miao on Jul 1, 2020 12:59:42 PM

Over these past few months, we here at ABclonal have been working diligently to continue supplying necessary reagents to researchers, clinicians, and companies worldwide to facilitate their efforts during the COVID-19 pandemic. In direct support of that goal, we’re proud to introduce our new, comprehensive line of SARS-CoV-2 ELISA kits.

 

A Closer Look at Asymptomatic COVID-19 Cases

Posted by Dennis Miao on Jun 22, 2020 3:01:18 PM

As we’ve seen over these past few months, a SARS-CoV-2 infection can result in widely different manifestations and severities in the subsequent course of the disease it causes, COVID-19. Many of those infected by SARS-CoV-2 experience a mild to severe illness, with symptoms that include fever, shortness of breath, cough, and fatigue that appear roughly 2-14 days after exposure to the virus. On the other hand, some individuals infected with the virus will remain asymptomatic. 

A Closer Look at COVID-19 Treatment and Vaccine Development

Posted by Dennis Miao on Jun 3, 2020 5:21:53 PM

With troves of information and developments coming out daily from the various companies and researchers developing vaccines and potential treatments for COVID-19, it can certainly feel overwhelming to keep track of everything. This compilation of information should help you catch up on, and navigate recent developments in the fight against COVID-19.